Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab.
Abdallah N, Murray D, Dispenzieri A, Kapoor P, Gertz MA, Lacy MQ, Hayman SR, Buadi FK, Gonsalves W, Muchtar E, Leung N, Dingli D, Kourelis T, Warsame R, Binder M, Kyle RA, Rajkumar SV, Kumar S.
Abdallah N, et al. Among authors: binder m.
Leukemia. 2024 Jun 17. doi: 10.1038/s41375-024-02308-5. Online ahead of print.
Leukemia. 2024.
PMID: 38886491
No abstract available.